Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
12 p, 926.4 KB Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines / García-Alfonso, Pilar (Hospital General Universitario Gregorio Marañón) ; Saiz-Rodríguez, M. (Hospital Universitario de Burgos) ; Mondéjar, R. (Hospital Universitario de la Princesa (Madrid)) ; Salazar, Juliana (Institut d'Investigació Biomèdica Sant Pau) ; Páez, David (Institut d'Investigació Biomèdica Sant Pau) ; Borobia, Alberto M (Hospital Universitario La Paz (Madrid)) ; Safont, M. J. (Universitat de València) ; García-García, Irene (Hospital 12 de Octubre (Madrid)) ; Colomer, Ramon (Hospital Universitario de la Princesa (Madrid)) ; García-González, Xandra (Hospital General Universitario Gregorio Marañón) ; Herrero Cervera, María José (Universitat de València) ; López-Fernández, L. A. (Hospital General Universitario Gregorio Marañón) ; Abad-Santos, Francisco (Hospital Universitario de la Princesa (Madrid)) ; Universitat Autònoma de Barcelona
5-Fluorouracil (5-FU) and oral fluoropyrimidines, such as capecitabine, are widely used in the treatment of cancer, especially gastrointestinal tumors and breast cancer, but their administration can produce serious and even lethal toxicity. [...]
2021 - 10.1007/s12094-021-02708-4
Clinical & Translational Oncology, Vol. 24 (november 2021) , p. 483-494  

See also: similar author names
1 López-Fernández, L. A.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.